C21orf2 antibody
Quick Overview for C21orf2 antibody (ABIN7469279)
Target
See all C21orf2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Cross-Reactivity
- Human
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein encompassing a sequence within the center region of human C21orf2. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Comment
-
Positive Control: Jurkat
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.72 mg/mL
-
Buffer
- 0.1M Tris-Glycine ( pH 7), 20 % Glycerol, 0.01 % Thimerosal
-
Preservative
- Thimerosal (Merthiolate)
-
Precaution of Use
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- C21orf2 (Chromosome 21 Open Reading Frame 2 (C21orf2))
-
Alternative Name
- C21orf2
-
Background
- Cilia and flagella associated protein 410 , C21orf2 , LRRC76 , RDMS , SMDAX , YF5/A2
-
Molecular Weight
- 28 kDa
-
Gene ID
- 755
-
UniProt
- O43822
Target
-